Queen Mary Innovation

Dr Johann Grundlingh presented a lecture on developing the Valsalva Manoeuvre device at Research Matters: Changing lives in East London and beyond

2 June 2016

Dr Johann Grundlingh, Consultant in Emergency Medicine presented a well-received lecture on Innovation in research and developing the Valsalva Manoeuvre device on 24 May 2016 at  the Research Matters Conference. As an emergency medicine consultant he frequently deals with life-threatening conditions with often easy solutions. Together with co-inventor Dr Ali Refson, Consultant in Emergency Medicine at Imperial College Healthcare NHS Trust they saw a need for the management of a common condition, supraventricular tachycardia, in the Emergency Department. They invented a simple solution to this common problem and designed a product that will hopefully change the lives of the people using it. The resultant product itself is small, hand-held, easy to use and non-invasive device, which can produce a Valsalva response for the treatment of supraventricular arrhythmias. It is envisaged that the device will be available to general practice, pre-hospital care, emergency departments and in-patient for the treatment of SVTs. It will also allow patients OTC access to treat their own arrhythmia and will therefore reduce the need for hospital treatment.

The team that is supported by Queen Mary Innovation Ltd and Barts Health NHS Tust is currently raising funds to evaluate the device in a clinical trial.